NIH ACTIV initiative launches adaptive clinical trials of blood-clotting treatments for COVID-19
10/09/2020
The trials will be conducted at more than 100 sites around the world and will involve patients in various clinical settings.
The trials will be conducted at more than 100 sites around the world and will involve patients in various clinical settings.